Monsanto Company (NYSE:MON)‘s stock had its “buy” rating restated by research analysts at BMO Capital Markets in a report issued on Thursday. They currently have a $128.00 price objective on the basic materials company’s stock. BMO Capital Markets’ price objective would suggest a potential upside of 6.89% from the stock’s previous close.

MON has been the topic of a number of other reports. Zacks Investment Research downgraded shares of Monsanto from a “buy” rating to a “hold” rating in a report on Tuesday, September 5th. BidaskClub raised shares of Monsanto from a “sell” rating to a “hold” rating in a report on Saturday, August 19th. Royal Bank Of Canada reissued a “sector perform” rating and set a $128.00 price target (up from $120.00) on shares of Monsanto in a report on Thursday, June 29th. Vetr raised shares of Monsanto from a “hold” rating to a “buy” rating and set a $122.35 price target on the stock in a report on Wednesday, July 12th. Finally, Jefferies Group LLC downgraded shares of Monsanto from a “buy” rating to a “hold” rating and set a $128.00 price target on the stock. in a report on Wednesday, July 12th. Ten analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $125.33.

Monsanto (MON) opened at 119.75 on Thursday. The stock has a market cap of $52.61 billion, a PE ratio of 25.86 and a beta of 1.07. Monsanto has a 1-year low of $97.35 and a 1-year high of $120.50. The company’s 50 day moving average is $118.11 and its 200-day moving average is $116.97.

Monsanto (NYSE:MON) last released its quarterly earnings data on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.41) by $0.61. Monsanto had a net margin of 14.11% and a return on equity of 45.26%. The firm had revenue of $2.69 billion for the quarter, compared to analyst estimates of $2.51 billion. During the same quarter in the prior year, the business earned $0.07 earnings per share. The business’s quarterly revenue was up 4.8% compared to the same quarter last year. Equities research analysts forecast that Monsanto will post $4.91 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This report was originally reported by Marea Informative and is the property of of Marea Informative. If you are viewing this report on another publication, it was illegally stolen and republished in violation of international copyright & trademark law. The correct version of this report can be viewed at http://www.mareainformativa.com/monsanto-company-mon-receives-buy-rating-from-bmo-capital-markets/116462/.

In other news, EVP Robert T. Fraley sold 52,410 shares of the firm’s stock in a transaction dated Monday, July 10th. The shares were sold at an average price of $117.95, for a total value of $6,181,759.50. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, VP Duraiswami Narain sold 2,860 shares of the firm’s stock in a transaction dated Monday, September 25th. The stock was sold at an average price of $120.00, for a total transaction of $343,200.00. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 77,910 shares of company stock worth $9,242,439. Insiders own 0.79% of the company’s stock.

Several large investors have recently bought and sold shares of the company. Puplava Financial Services Inc. lifted its stake in shares of Monsanto by 0.4% in the second quarter. Puplava Financial Services Inc. now owns 2,119 shares of the basic materials company’s stock worth $251,000 after buying an additional 9 shares in the last quarter. Savant Capital LLC lifted its stake in shares of Monsanto by 0.4% in the first quarter. Savant Capital LLC now owns 3,082 shares of the basic materials company’s stock worth $349,000 after buying an additional 11 shares in the last quarter. Guardian Life Insurance Co. of America lifted its stake in shares of Monsanto by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,689 shares of the basic materials company’s stock worth $191,000 after buying an additional 11 shares in the last quarter. Enterprise Financial Services Corp lifted its stake in shares of Monsanto by 1.2% in the second quarter. Enterprise Financial Services Corp now owns 1,384 shares of the basic materials company’s stock worth $164,000 after buying an additional 16 shares in the last quarter. Finally, Forward Management LLC lifted its stake in shares of Monsanto by 0.5% in the second quarter. Forward Management LLC now owns 3,201 shares of the basic materials company’s stock worth $379,000 after buying an additional 16 shares in the last quarter. 74.81% of the stock is currently owned by hedge funds and other institutional investors.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Analyst Recommendations for Monsanto (NYSE:MON)

Receive News & Stock Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related stocks with our FREE daily email newsletter.